Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals

American Journal on Addictions

Volumn 21, Issue 1, 2012, Pages 5-10

  Arias, Albert J ^a,b,c   Chan, Grace ^a,b   Gelernter, Joel ^b,c   Farrer, Lindsay ^d   Kranzler, Henry R ^a,b,e,f  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; OPIATE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DEPENDENCE; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PHENOTYPE; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDAL BEHAVIOR; SUICIDE RELATED OUTCOME;

ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; SYNAPTIC TRANSMISSION;

EID: 84855341529     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00195.x     Document Type: Article

References (41)

1. Hawton K, van Heeringen K,. Suicide. Lancet. 2009; 373: 1372-1381.
2. Borges G, Angst J, Nock MK, et al,. A risk index for 12-month suicide attempts in the National Comorbidity Survey Replication (NCS-R). Psychol Med. 2006; 36: 1747-1757. (Pubitemid 44824736)
3. Bertolote JM, Fleischmann A,. Suicidal behavior prevention: WHO perspectives on research. Am J Med Genet C Semin Med Genet. 2005; 133C: 8-12. (Pubitemid 40194124)
4. Baca-Garcia E, Perez-Rodriguez MM, Keyes KM, et al,. Suicidal ideation and suicide attempts in the United States: 1991-1992 and 2001-2002. Mol Psychiatry. 2010; 15: 250-259.
5. Kessler RC, Borges G, Walters EE,. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry. 1999; 56: 617-626. (Pubitemid 29315633)
6. Nock MK, Borges G, Bromet EJ, et al,. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008; 192: 98-105. (Pubitemid 351269642)
7. Kessler RC, Berglund P, Borges G, et al,. Trends in suicide ideation, plans, gestures, and attempts in the United States,1990-1992 to 2001-2003. JAMA. 2005; 293: 2487-2495. (Pubitemid 40705730)
8. Mann JJ,. A current perspective of suicide and attempted suicide. Ann Intern Med. 2002; 136: 302-311. (Pubitemid 34150759)
9. Schneider B,. Substance use disorders and risk for completed suicide. Arch Suicide Res. 2009; 13: 303-316.
10. Sher L, Oquendo MA, Richardson-Vejlgaard R, et al,. Effect of acute alcohol use on the lethality of suicide attempts in patients with mood disorders. J Psychiatr Res. 2009; 43: 901-905.
11. Young AS, Nuechterlein KH, Mintz J, et al,. Suicidal ideation and suicide attempts in recent-onset schizophrenia. Schizophr Bull. 1998; 24: 629-634. (Pubitemid 28524631)
12. Voracek M, Loibl LM,. Genetics of suicide: A systematic review of twin studies. Wien Klin Wochenschr. 2007; 119: 463-475. (Pubitemid 47382919)
13. Brezo J, Klempan T, Turecki G,. The genetics of suicide: A critical review of molecular studies. Psychiatr Clin North Am. 2008; 31: 179-203. (Pubitemid 351551424)
14. Pedersen NL, Fiske A,. Genetic influences on suicide and nonfatal suicidal behavior: Twin study findings. Eur Psychiatry. 2010; 25: 264-267.
15. Baldessarini RJ, Hennen J,. Genetics of suicide: An overview. Harv Rev Psychiatry. 2004; 12: 1-13. (Pubitemid 38295893)
16. Brent DA, Mann JJ,. Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet. 2005; 133C: 13-24. (Pubitemid 40194125)
17. Carballo JJ, Akamnonu CP, Oquendo MA,. Neurobiology of suicidal behavior. An integration of biological and clinical findings. Arch Suicide Res. 2008; 12: 93-110.
18. Scarone S, Gambini O, Calabrese G, et al,. Asymmetrical distribution of beta-endorphin in cerebral hemispheres of suicides: Preliminary data. Psychiatry Res. 1990; 32: 159-166. (Pubitemid 20178403)
19. Gabilondo AM, Meana JJ, Garcia-Sevilla JA,. Increased density of mu-opioid receptors in the postmortem brain of suicide victims. Brain Res. 1995; 682: 245-250.
20. Gross-Isseroff R, Dillon KA, Israeli M, et al,. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res. 1990; 530: 312-316. (Pubitemid 20340713)
21. Escriba PV, Ozaita A, Garcia-Sevilla JA,. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology. 2004; 29: 1512-1521. (Pubitemid 38982244)
22. Zalsman G, Molcho A, Huang Y, et al,. Postmortem mu-opioid receptor binding in suicide victims and controls. J Neural Transm. 2005; 112: 949-954. (Pubitemid 40869083)
23. Cheng R, Juo SH, Loth JE, et al,. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry. 2006; 11: 252-260.
24. Hishimoto A, Cui H, Mouri K, et al,. A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. J Neural Transm. 2008; 115: 531-536.
25. Kroslak T, Laforge KS, Gianotti RJ, et al,. The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem. 2007; 103: 77-87. (Pubitemid 47404205)
26. Zhang Y, Wang D, Johnson AD, et al,. Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem. 2005; 280: 32618-32624. (Pubitemid 41368304)
27. Hernandez-Avila CA, Wand G, Luo X, et al,. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet. 2003; 118B: 60-65. (Pubitemid 37064077)
28. Wand GS, McCaul M, Yang X, et al,. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology. 2002; 26: 106-114. (Pubitemid 34075281)
29. Chong RY, Oswald L, Yang X, et al,. The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress. Neuropsychopharmacology. 2006; 31: 204-211. (Pubitemid 43250957)
30. Chinn S,. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000; 19: 3127-3131.
31. Gelernter J, Panhuysen C, Weiss R, et al,. Genomewide linkage scan for cocaine dependence and related traits: Significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am J Med Genet B Neuropsychiatr Genet. 2005; 136B: 45-52. (Pubitemid 40917527)
32. Gelernter J, Panhuysen C, Wilcox M, et al,. Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet. 2006; 78: 759-769.
33. Arias A, Feinn R, Kranzler HR,. Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: A meta-analysis. Drug Alcohol Depend. 2006; 83: 262-268.
34. Pierucci-Lagha A, Gelernter J, Chan G, et al,. Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend. 2007; 91: 85-90. (Pubitemid 47398866)
35. Pierucci-Lagha A, Gelernter J, Feinn R, et al,. Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Depend. 2005; 80: 303-312. (Pubitemid 41660851)
36. Zhang H, Luo X, Kranzler HR, et al,. Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet. 2006; 15: 807-819. (Pubitemid 43338224)
37. Liang K-Y, Zeger SL,. Longitudinal data analysis using generalized linear models. Biometrika. 1986; 73: 13-22.
38. Wigginton JE, Cutler DJ, Abecasis GR,. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet. 2005; 76: 887-893. (Pubitemid 40563110)
39. Tu XM, Kowalski J, Zhang J, et al,. Power analyses for longitudinal trials and other clustered designs. Stat Med. 2004; 23: 2799-2815. (Pubitemid 39207203)
40. Salanti G, Amountza G, Ntzani EE, et al,. Hardy-Weinberg equilibrium in genetic association studies: An empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005; 13: 840-848. (Pubitemid 40946083)
41. Trikalinos TA, Salanti G, Khoury MJ, et al,. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am J Epidemiol. 2006; 163: 300-309. (Pubitemid 43238423)